Atom Grants
Discover
  • Dashboard
  • Search
  • Deep Research
  • Favorites
  • Projects

    Neuromodulation/Neurostimulation Device Development for Mental Health Applications (R21 Clinical Trial Not Allowed)

    This grant supports developing advanced brain stimulation devices for treating mental health disorders, focusing on novel techniques and significant improvements to existing FDA-approved devices.

    Browse similar grants
    Neuroscience Research Grants 2026
    OverviewSimilar Grants
    OverviewSimilar Grants

    Funder: National Institutes of Health

    Due Dates: February 16, 2027 (New) | March 16, 2027 (Resubmission/revision) | June 16, 2027 (New) | July 16, 2027 (Resubmission/revision) | October 16, 2027 (New) | November 16, 2027 (Resubmission/revision) | January 7, 2028 (Closing)

    Funding Amounts: Up to $275,000 in direct costs over two years, with no more than $200,000 in any year

    Summary: Supports engineering development of novel brain stimulation devices or significant improvements to existing devices for mental health treatment.

    Key Information: Multidisciplinary teams are required; clinical trials and incremental device improvements are not allowed.


    Description

    The National Institute of Mental Health (NIMH) supports next-generation brain stimulation devices through this NIH R21 exploratory/developmental research opportunity (PAR-25-286). Projects may develop novel invasive or non-invasive devices or significantly enhance FDA-approved or cleared devices through hardware or software innovations. Priorities include greater spatial and temporal precision, deeper stimulation, multi-focal interfaces, and closed-loop approaches.

    The program emphasizes engineering development, bench testing, and validation rather than hypothesis-driven studies that simply use devices. It supports shorter, high-risk proof-of-concept projects, including those without preliminary data, and smaller projects closer to final form. Animal studies and limited human testing that does not constitute a clinical trial are allowable when necessary for initial proof of concept. All tools must be designed for eventual human use.


    Atom

    See the full grant listing

    Sign in to view full eligibility details, sources, similar grants, and AI-powered analysis.